A Non-pharmacological Cough Control Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorWest Park Healthcare Centre

About this trial

Coughing affects almost all individuals with ILD leading to physical, psychological and social distress and prevents individuals from performing their activities of daily living, working or socialising in public places. Unfortunately, there are no licensed medications available to treat chronic cough and the few drugs that have been tried resulted in little efficacy and significant side effects. Drug-free cough control interventions have shown promise in reducing the severity and impact of coughing on patients' lives but have not been tested in individuals with ILD. This study aims to explore the feasibility and effectiveness of a non-pharmacological cough control therapy, as an adjuvant of pulmonary rehabilitation, in patients with ILD and chronic cough (\>8 weeks in duration).

Eligibility criteria

Qualifiers

Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating patients with fibrotic interstitial lung disease) and a chronic cough lasting more than 8 weeks in duration

Disqualifiers

self-reports of moderate or large sputum production

effective or suspected exacerbation of the respiratory condition in the past month

upper respiratory tract infection in the past month

use of angiotensin-converting enzyme inhibitor medication

Trial design

Treatments tested in this trial

  • Non-pharmacological Cough control Therapy

Treatment groups

24 Participants
are divided into 1 treatment group

Sponsors and collaborators

West Park Healthcare Centre

Lead sponsor

St. Joseph's Healthcare Hamilton

Collaborator